AstraZeneca Community
Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
NA
NateF
Community Contributor
AZN Market Outlook
AstraZeneca PLC (AZN) is a prominent player in the pharmaceutical industry, with a diverse portfolio and a strong focus on innovation. Has recently demonstrated robust financial performance, with notable developments that may influence its market position over the next 1-3 years.
View narrativeUS$130.22
FV
47.0% undervalued intrinsic discount6.26%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
about 1 month ago author updated this narrative
WA
Consensus Narrative from 19 Analysts
Disciplined Investment in Growth Areas and Emerging Markets Fuels Revenue Surge
AstraZeneca focuses on high-growth potential areas like oncology and aims for substantial growth in emerging markets, significantly impacting future revenues. Commitment to mid-30s operating margin and disciplined investment in R&D and product pipeline underpins long-term growth and profitability.
View narrativeUS$128.13
FV
46.2% undervalued intrinsic discount0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7 months ago author updated this narrative